Release date: 2026-01-05 14:28:47 Recommended: 14
It is mainly indicated for the treatment of metastatic non-small cell lung cancer (NSCLC) harboring specific gene mutations (EGFR exon 19 deletion or exon 21 L858R substitution mutation), as well as f